{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:13:30Z","timestamp":1762506810605,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jceh.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T14:29:47Z","timestamp":1463927387000},"page":"246-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Sern Wei","family":"Yeoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2016.05.006_bib0080","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2016.05.006_bib0085","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.4158\/EP13122.CR","article-title":"Iatrogenic Cushing syndrome in patients receiving inhaled budesonide and itraconazole or ritonavir: two cases and literature review","volume":"19","author":"Blondin","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jceh.2016.05.006_bib0090","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/02770903.2010.485666","article-title":"Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient","volume":"47","author":"Kedem","year":"2010","journal-title":"J Asthma"},{"key":"10.1016\/j.jceh.2016.05.006_bib0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7196\/SAMJ.3848","article-title":"Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide","volume":"100","author":"Gray","year":"2010","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jceh.2016.05.006_bib0100","first-page":"120","article-title":"Inhaled corticosteroids in persons with HIV infection: not that harmless","volume":"67","author":"Spruyt","year":"2012","journal-title":"Acta Clin Belg"},{"issue":"2","key":"10.1016\/j.jceh.2016.05.006_bib0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1468-1293.2001.00058.x","article-title":"Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy","volume":"2","author":"le Roux","year":"2001","journal-title":"HIV Med"},{"issue":"7","key":"10.1016\/j.jceh.2016.05.006_bib0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1258\/ijsa.2011.011408","article-title":"Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection","volume":"23","author":"Yoganathan","year":"2012","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jceh.2016.05.006_bib0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1345\/aph.1P731","article-title":"Cushing's syndrome due to antiretroviral\u2013budesonide interaction","volume":"45","author":"Frankel","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jceh.2016.05.006_bib0120","first-page":"803","article-title":"Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease","volume":"43","author":"Edsb\u00e4cker","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jceh.2016.05.006_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000073224","article-title":"Inhibition of cytochrome P4503A: relevant drug interactions in gastroenterology","volume":"68","author":"Sagir","year":"2003","journal-title":"Digestion"},{"issue":"17","key":"10.1016\/j.jceh.2016.05.006_bib0130","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMoa1401561","article-title":"Retreatment of HCV with ABT-450\/r-ombitasvir and dasabuvir with ribavirin","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jceh.2016.05.006_bib0135","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N Engl J Med"},{"issue":"10017","key":"10.1016\/j.jceh.2016.05.006_bib0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(16)00212-9","article-title":"Australia commits funds to curb hepatitis C epidemic","volume":"387","author":"McCall","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jceh.2016.05.006_bib0145","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/1060028015576180","article-title":"Drug interactions with direct-acting antivirals for hepatitis C: implications for HIV and transplant patients","volume":"49","author":"Burgess","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jceh.2016.05.006_bib0150","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.078","article-title":"Efficacy of direct-acting antiviral combination for patients with hepatitis C virus genotype 1 infection and severe renal impairment or end-stage renal disease","author":"Pockros","year":"2016","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688316300615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688316300615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:48Z","timestamp":1760853828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688316300615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0973688316300615"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2016.05.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 INASL.","name":"copyright","label":"Copyright"}]}}